Clinical Trials Logo

Clinical Trial Summary

This is an open label 6 month pilot study for male and female participants over the age of 52 that desire treatment and prevention of senile purpura of the forearms.

This study will be evaluating the effects of Adapalene 0.3% for the use in the treatment and prevention of senile purpura.


Clinical Trial Description

This is a new potential use for the product Adapalene 0.3%, which is currently an FDA approved topical treatment used for the treatment of acne.

Senile purpura is a common sign of aging that appears in the form of dark blotches on the skin and is caused by bruising.

Older adults tend to be more prone to bruising, since as people age, their skin becomes thinner and more fragile. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01485367
Study type Interventional
Source Multispecialty Aesthetic Clinical Research Organization
Contact Ronnie Zocks, BS
Phone (310) 963-5001
Email macroclinicaltrials@gmail.com
Status Recruiting
Phase Phase 2
Start date December 2011
Completion date December 2012

See also
  Status Clinical Trial Phase
Completed NCT03690375 - Broad Band Light for the Treatment and Prevention of Senile Purpura N/A
Completed NCT05037604 - Factors Associated With Dermatoporosis